| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Assessing clonal changes in T cells over time following immunotherapy is a breeze with Cyclone
|
Cillo, Anthony R.
|
|
|
42 |
9 |
p. 1491-1493
|
article
|
| 2 |
Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
|
Tirosh, Itay
|
|
|
42 |
9 |
p. 1497-1506
|
article
|
| 3 |
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer
|
Xu, Jiachen
|
|
|
42 |
9 |
p. 1598-1613.e4
|
article
|
| 4 |
Classifying cancer-associated fibroblasts—The good, the bad, and the target
|
Cords, Lena
|
|
|
42 |
9 |
p. 1480-1485
|
article
|
| 5 |
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
|
Wang, Kevin
|
|
|
42 |
9 |
p. 1582-1597.e10
|
article
|
| 6 |
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
|
McIntyre, Caitlin A.
|
|
|
42 |
9 |
p. 1614-1629.e5
|
article
|
| 7 |
Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial
|
Xiao, Wei-Wei
|
|
|
42 |
9 |
p. 1570-1581.e4
|
article
|
| 8 |
Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence
|
Watson, Spencer S.
|
|
|
42 |
9 |
p. 1507-1527.e11
|
article
|
| 9 |
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
|
Liu, Ilon
|
|
|
42 |
9 |
p. 1528-1548.e17
|
article
|
| 10 |
Glioblastoma induces the recruitment and differentiation of dendritic-like “hybrid” neutrophils from skull bone marrow
|
Lad, Meeki
|
|
|
42 |
9 |
p. 1549-1569.e16
|
article
|
| 11 |
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma
|
Sarkozy, Clémentine
|
|
|
42 |
9 |
p. 1630
|
article
|
| 12 |
Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy
|
Eide, Christopher A.
|
|
|
42 |
9 |
p. 1486-1488
|
article
|
| 13 |
PD-1 blockade is a promising therapeutic addition to neoadjuvant chemoradiation in locally advanced rectal cancer
|
Somasundaram, Ashwin
|
|
|
42 |
9 |
p. 1489-1491
|
article
|
| 14 |
Precision oncology across the ages: Impact on children, adolescents, and young adults
|
Subbiah, Vivek
|
|
|
42 |
9 |
p. 1473-1479
|
article
|
| 15 |
The KRAS mutational spectrum and its clinical implications in pancreatic cancer
|
Perelli, Luigi
|
|
|
42 |
9 |
p. 1494-1496
|
article
|
Journal description